Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

10108	Companies
207161	Keywords
137291	Articles
109798	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 09/04/2025 at 09:46, 6 months 24 days ago

Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2025
Heidelberg Pharma announces new clinical data for lead ATAC candidate HDP-101 to be presented at the International Myeloma Society Annual Meeting 2025

Clinical Data Heidelberg Pharma HDP-101 ATAC Candidate International Myeloma Society
BRIEF

published on 08/28/2025 at 03:55, 7 months ago

La FDA demande des données supplémentaires à Telix Pharmaceuticals, retardant ainsi le paiement à Heidelberg Pharma

Heidelberg Pharma Mise À Jour Réglementaire TLX250-CDx Conséquences Financières Demande De La FDA
BRIEF

published on 08/28/2025 at 03:55, 7 months ago

FDA Requests Additional Data from Telix Pharmaceuticals, Delaying Payment to Heidelberg Pharma

Heidelberg Pharma Regulatory Update TLX250-CDx FDA Request Financial Implications
PRESS RELEASE

published on 08/28/2025 at 03:50, 7 months ago

EQS-Adhoc: Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
Heidelberg Pharma's partner Telix Pharmaceuticals faces delays in TLX250-CDx FDA approval. USD 70 million payment from HealthCare Royalty postponed. Current cash reach until Q1 2026

FDA Approval Heidelberg Pharma HealthCare Royalty Telix Pharmaceuticals TLX250-CDx
BRIEF

published on 07/10/2025 at 07:08, 8 months 18 days ago

Heidelberg Pharma's Promising Mid-Year 2025 Developments

Leadership Changes Royalty Agreement Financial Developments HDP-101 Trials HDP-102 Introduction
BRIEF

published on 07/10/2025 at 07:08, 8 months 18 days ago

Développements prometteurs de Heidelberg Pharma pour la mi-année 2025

Changements De Direction Évolution Financière Accord De Redevances Essais HDP-101 Présentation Du HDP-102
PRESS RELEASE

published on 07/10/2025 at 07:03, 8 months 18 days ago

Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business
Heidelberg Pharma AG reports on positive first half-year 2025 business performance including advancements in ATAC candidates HDP-101 and HDP-102. Financial figures show promising results in line with planning

Financial Report Clinical Trials HDP-101 Heidelberg Pharma AG ATAC Candidates
BRIEF

published on 05/27/2025 at 08:12, 10 months 1 day ago

Heidelberg Pharma Begins Phase I Study for HDP-102 in Non-Hodgkin Lymphoma

Heidelberg Pharma ADC Technology HDP-102 Non-Hodgkin Lymphoma Phase I Study
BRIEF

published on 05/27/2025 at 08:12, 10 months 1 day ago

Heidelberg Pharma lance une étude de phase I pour le HDP-102 dans le lymphome non hodgkinien

Heidelberg Pharma Technologie ADC HDP-102 Lymphome Non Hodgkinien Étude De Phase I
PRESS RELEASE

published on 05/27/2025 at 08:07, 10 months 1 day ago

Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma
Heidelberg Pharma dosed first patient in Phase I study of Amanitin-based ADC HDP-102 for Non-Hodgkin Lymphoma. ATAC technology targeting CD37. Promising data presented at AACR 2024

Heidelberg Pharma ATAC Technology Amanitin-based ADC Non-Hodgkin Lymphoma Phase I Study

Accesswire

Published on 03/28/2026 at 01:00, 1 day 1 hour ago

Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 1 day 1 hour ago

Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 1 day 1 hour ago

"Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 1 day 3 hours ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 1 day 3 hours ago

Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property

View all ACCESSWIRE

EQS Group

Published on 03/28/2026 at 10:05, 16 hours 14 minutes ago

Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 17 hours 23 minutes ago

Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 1 day ago

EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 1 day 4 hours ago

Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 1 day 4 hours ago

Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025

Les Echos

Published on 03/28/2026 at 07:00, 19 hours 19 minutes ago

Groupe DLSI - Résultat 2025
Published on 03/27/2026 at 19:06, 1 day 7 hours ago

Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 19:06, 1 day 7 hours ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 1 day 7 hours ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 1 day 7 hours ago

Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025

View all LES ECHOS COMFI WIRE